trending Market Intelligence /marketintelligence/en/news-insights/trending/xAVoGdvDhDEuMxQ-WsZIww2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Rexahn Pharmaceuticals transfers listing to Nasdaq Capital Market

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates


Rexahn Pharmaceuticals transfers listing to Nasdaq Capital Market

Rexahn Pharmaceuticals Inc. said it will transfer its listing from the NYSE American exchange to the Nasdaq Capital Market.

The Rockville, Md.-based biotechnology company, which develops treatments for cancer, expects to start trading on Nasdaq under the symbol REXN on or about June 10.

The company's stock will continue to trade on the NYSE American under the symbol RNN until the transfer is completed.